Progenics Pharmaceuticals stock soars 29% on news of positive results in prostate cancer drug trial [MarketWatch]
PROGENICS PHARMACEUTICALS (PGNX)
Last progenics pharmaceuticals earnings: 8/9 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
progenics.com
Company Research
Source: MarketWatch
Progenics Pharmaceuticals stock soars 29% on news of positive results in prostate cancer drug trial Progenics Pharmaceuticals, Inc. PGNX, -1.34% said Monday a late-stage trial of a treatment for prostate cancer met its main goal. The New York-based company said the phase 3 trial called Condor evaluating the diagnostic performance of PyL(TM) ((18) F-DCFPyL) in men with biochemical recurrence of prostate cancer met its primary endpoint of improving the visualization of the disease. The trail involved 208 patients at 14 sites in the U.S. and Canada. The company is planning to file a new drug application to the U.S. Food and Drug Administration in the second half of 2020. Shares rose 29% after resuming trade following a halt for the news. The stock has gained 23% in the year through Friday, while the S&P 500 SPX, +0.49% has gained 28.5%.
Show less
Read more
Impact Snapshot
Event Time:
PGNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PGNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PGNX alerts
High impacting PROGENICS PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics